Business Wire

KPMG-INTERNATIONAL

Share
KPMG delivers strong global revenues, reporting 14% growth in FY22

KPMG International announces strong annual aggregated revenues for KPMG firms globally of US$35 billion for the fiscal year ending 30 September 2022 (FY22) — an increase of 14%.*

During continued economic and geopolitical uncertainty, robust numbers and consistent growth were achieved across all functions. Advisory achieved the largest growth increase — up 19% on FY21 across KPMG firms globally. Growth was driven by the success of Transaction and Deal Advisory services, as well as continued demand for innovative technologies and advanced cyber security solutions. Tax & Legal Services experienced 10% growth while Audit grew 8%, benefiting from a combination of the investments made in technology and our KPMG firms’ connected local knowledge.

“FY22 has been a strong year. KPMG firms’ financial performance validates an unwavering commitment to deliver services of the highest quality through a multi-disciplinary approach that helps provide solutions to clients’ most difficult challenges and the stability and resilience to invest, even in hard times.

But the true measure of our success is what we’ve been able to accomplish for those that rely on us most. Clients and wider society continue to face complex problems that require KPMG professionals to work across borders and disciplines and to collaborate more closely than ever. Few organizations have the expertise and global reach that KPMG has, and we’re at our best when we work together to inspire confidence and empower change.”

Bill Thomas, Global Chairman and CEO, KPMG International

Talent

The KPMG global organization’s worldwide headcount continues to grow, increasing by 12.4% in FY22, bolstered by more than 29,000 net new roles created. This growth has led to the addition of specialists and subject-matter experts at all levels, helping to enable high-quality and multi-disciplinary services designed to solve the complex problems of modern organizations around the world.

KPMG’s commitment to inclusion, diversity and equity (IDE) remains; women represent 48.5% of all KPMG professionals and we have achieved gender parity on the Global Management Team.

Bill Thomas commented: “This year’s growth will help us continue to invest in our people — which remains critical in a competitive marketplace for talent. Ensuring KPMG professionals are working on diverse projects that are making a positive difference and providing them with a flexible career path in an inclusive and caring environment are priorities for us. Keeping people motivated and happy is fundamental to success, and that’s why we’re so focused on the continued development of our culture that puts our purpose and Values at the heart of everything we do.”

Technology

The past year has seen the demand for technology-enabled transformation rise dramatically, reshaping many businesses, including our own. KPMG continues to make significant investments across the organization in digital transformation, including the appointment of Lisa Heneghan, as the Global Chief Digital Officer. Over the last year, KPMG professionals have helped clients transform their business model or processes, leading to more than 20% growth in revenue in this area from FY21 that is largely driven by digital transformation work — a testament to KPMG firms’ offerings: “Connected. Powered. Trusted. Elevate.” and the power of our alliance-driven digital solutions with globally recognized technology organizations.

Technology enables everything KPMG firms do as digital businesses and continues to drive investments in compliance and strategic tax advisory services. KPMG Digital Gateway, a cloud-native platform solution powered by Microsoft Azure, provides clients with access to a full suite of tax and legal technologies across 140 jurisdictions, helping organizations turn data into value when faced with huge shifts in the global tax policy and regulatory landscape.

More and more global organizations have looked to cloud technologies for growth opportunities, and through the power of our global delivery centers, the KPMG Delivery Network, KPMG firms have harnessed the agility and power of our global teams to extend the power and reach of technology solutions.

KPMG has invested significantly in our system of quality management throughout the organization, enabling compliance with new industry-wide global quality management standards. Following its rollout two years ago, KPMG Clara, our global, cloud-enabled, smart audit platform, also powered by Microsoft Azure, is used by nearly all 90,000 audit professionals across the 143 countries and territories that KPMG firms operate in.

KPMG Clara is an important step in KPMG’s journey to innovate and digitalize Audit. As part of our ongoing commitment to audit quality, consistency and innovation, the platform is a significant investment that integrates new and emerging technologies, with advanced capabilities that leverage data science, audit automation, and data visualization.

Environmental, social and governance (ESG)

ESG remains the watermark running through the organization and steady financial growth has underpinned investment in industry-leading global environmental, social and governance (ESG) solutions — in line with the US$1.5 billion investment commitment we made in 2021.

KPMG professionals’ focus on delivering multi-disciplinary client solutions to maximize the opportunities and address the challenges presented by the ESG agenda includes the creation of a global climate change and decarbonization hub to provide emerging technology expertise and decarbonization support and the launch of the sustainability reporting resource center to provide guidance in preparation for the International Sustainability Standards Board’s (ISSB) forthcoming Sustainability Disclosure Standards.

To date, almost 100,000 KPMG professionals have undertaken specialist ESG 101 training. This program, of learning for a lifetime, will continue.

For more on KPMG’s commitment to quality: KPMG International 2022 Transparency Report

For more of KPMG’s Corporate Highlights in FY22, including stories of KPMG professionals and how they’ve worked shoulder-to-shoulder with clients, visit: www.kpmg.com/corporatereporting

About KPMG International

KPMG is a global organization of independent professional services firms providing Audit, Tax and Advisory services. KPMG is the brand under which the member firms of KPMG International Limited (“KPMG International”) operate and provide professional services. “KPMG” is used to refer to individual member firms within the KPMG organization or to one or more member firms collectively.

KPMG firms operate in 143 countries and territories with more than 265,000 partners and employees working in member firms around the world. Each KPMG firm is a legally distinct and separate entity and describes itself as such. Each KPMG member firm is responsible for its own obligations and liabilities.

KPMG International Limited is a private English company limited by guarantee. KPMG International Limited and its related entities do not provide services to clients.

For more detail about our structure, please visit home.kpmg/governance.

ENDS

Notes to editors:

KPMG FY22 member firm revenues (US$ billions)

Regions

FY22

FY21

Local
Growth

Americas

13.71

11.88

16%

Asia Pacific

6.31

5.97

13%

EMA

14.62

14.28

11%

Total

34.64

32.13

13%

Functions

FY22

FY21

Local
Growth

Audit

11.85

11.46

8%

Tax and Legal Services

7.35

7.02

10%

Advisory

15.44

13.65

19%

Total

34.64

32.13

13%

*14% is based on the growth in continuing operations and excludes the FY21 and FY22 revenues from businesses sold or countries from which KPMG exited during this period. When not restated, the revenue growth is 13% and all other growth rates in this press release are similarly not restated, unless highlighted.

Further information

The financial information set out represents combined information of the independent KPMG member firms that perform professional services for clients, affiliated with KPMG International Limited. The information is combined here solely for presentation purposes. KPMG International Limited performs no services for clients nor, concomitantly, generates any client revenue.

FY22 revenues throughout this press release, reflect KPMG’s financial year between 1 October 2021 and 30 September 2022 and are based on US dollar gross revenues, including travel and other client reimbursable expenses. Local growth percentages are based on maintaining consistent FY22 exchange rates within the prior year.

Headcount reported above based on partners and staff employed as of 30 September 2022.

Legal services may not be offered to SEC registrant audit clients or where otherwise prohibited by law.

Throughout this press release, “we”, “KPMG”, “us” and “our” refers to the global organization or to one or more of the member firms of KPMG International Limited (“KPMG International”), each of which is a separate legal entity. KPMG International Limited is a private English company limited by guarantee and does not provide services to clients. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221213005319/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Axelspace: Notice of Signing a Service contract for In-Orbit Demonstration with Pale Blue, Inc.22.12.2025 10:00:00 CET | Press release

Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” has entered into a service agreement with Pale Blue Inc. (“Pale Blue”), a company that develops, manufactures, and sells thrusters (engines) for small satellites, for an in-orbit demonstration, as detailed below. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219321165/en/ Jun Asakawa, Co-founder & CEO of Pale Blue (left in photo) and Yuya Nakamura, President and CEO of Axelspace Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Under this contract, an in-orbit demonstration of a fast-start Hall thruster developed by Pale Blue is scheduled to be conducted in 2027. Nonetheless, conducting in-orbit demonstrations in a short period of time is known to be a significant challenge due to the in

Axelspace Signing Agreement on a Multi-Launch Arrangement and the Launch of New Satellites with Exolaunch22.12.2025 10:00:00 CET | Press release

Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” is pleased to announce a multi-launch agreement (MLA) with Exolaunch, a global launch integrator and leader in launch mission management, satellite integration and satellite deployment technologies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219038364/en/ The Multi-Launch Agreement will accelerate the growth of Axelspace. In particular, one satellite scheduled for launch under the new Agreement will be used in the AxelLiner business’s in-orbit demonstration service, “AxelLiner Laboratory”. Exolaunch has already secured launches for eight (8) Axelspace’s satellites on the upcoming missions. Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Nonetheless, conducting in-orbit demonstration

Zambon Biotech Announces First Patient Dosed in Phase 3b ADIP Clinical Study of IPX203 in Parkinson’s Disease22.12.2025 10:00:00 CET | Press release

Zambon Biotech, a specialized biotech company part of the Zambon group that aims to build a scientifically robust and commercially viable portfolio of innovative patient-oriented drugs through the scouting, acquisition, licensing and development of new molecules, today announced that the first participant with advanced Parkinson’s disease has been enrolled in the European Phase 3b ADIP (IPX203 in Advanced Parkinson’s disease) study, which is planned to evaluate the efficacy and safety of IPX203 versus immediate-release (IR) levodopa/carbidopa (LD/CD) in a regimen which has not yet been the focus of a Phase 3 trial. IPX203 is a novel, oral modified-release formulation of LD/CD designed for the treatment of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health Organization1. IPX203 contains immediate-release granules and extended-release beads, providing both a rapid onset of action and a longer duration of benefit, sustaining the levo

Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor22.12.2025 09:00:00 CET | Press release

First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER studyIn MANEUVER, pimicotinib significantly improved objective response rate at week 25 (54% vs. 3.2% for placebo), while providing clinically meaningful and statistically significant improvements across all patient-reported outcomesWith longer-term follow-up, 3 out of 4 patients treated with pimicotinib achieved response per RECIST v1.1, and treatment continued to be well-toleratedApproval strengthens Merck’s leadership in rare tumors, with additional ongoing regulatory filings for pimicotinib underway globally Merck, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved pimicotinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause functional limitation or relatively severe morbidity.

Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma22.12.2025 08:44:00 CET | Press release

Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide for adult patients with relapsed or refractory follicular lymphoma (2L+ FL). “Today's approval of Minjuvi in combination with rituximab and lenalidomide marks a significant milestone as the first dual-targeted CD19 and CD20 immunotherapy combination for relapsed or refractory FL in Japan,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “By improving progression-free survival, Minjuvi offers a chemotherapy-free option for eligible patients with relapsed or refractory disease. This approval underscores our commitment to bridging critical treatment gaps to patients and families affected by this challenging disease in Japan.” The approval is based on the pivotal Phase 3 inMIND trial, which enrolled 654 adult patients, including patients based in Japan. The study demonstrated that Minjuvi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye